121 related articles for article (PubMed ID: 27776946)
1. [Survival of malignant and paramalignant pleural effusions in Ouagadougou].
Bambara AT; Ouédraogo SM; Maïga S; Sondo KA; Boncoungou/Nikièma K; Ouédraogo G; Koumbem B; Ouédraogo AS; Djibril M; Badoum G; Ouédraogo AR; Ouédraogo M
Rev Pneumol Clin; 2016 Dec; 72(6):346-352. PubMed ID: 27776946
[TBL] [Abstract][Full Text] [Related]
2. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
3. Important prognostic factors for survival in patients with malignant pleural effusion.
Zamboni MM; da Silva CT; Baretta R; Cunha ET; Cardoso GP
BMC Pulm Med; 2015 Mar; 15():29. PubMed ID: 25887349
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors affecting survival in non-small cell lung carcinoma patients with malignant pleural effusions.
Kasapoglu US; Arınç S; Gungor S; Irmak I; Guney P; Aksoy F; Bandak D; Hazar A
Clin Respir J; 2016 Nov; 10(6):791-799. PubMed ID: 25764010
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of Cancer with Synchronous or Metachronous Malignant Pleural Effusion.
Porcel JM; Solé C; Salud A; Bielsa S
Lung; 2017 Dec; 195(6):775-779. PubMed ID: 28900718
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
[TBL] [Abstract][Full Text] [Related]
7. Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion.
Takeuchi E; Okano Y; Machida H; Atagi K; Kondou Y; Kadota N; Hatakeyama N; Naruse K; Shinohara T
Cancer Immunol Immunother; 2022 Feb; 71(2):365-372. PubMed ID: 34170380
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in patients with malignant pleural effusion: Is it possible to predict mortality in patients with good performance status?
Abrao FC; Peixoto RD; de Abreu IR; Janini MC; Viana GG; de Oliveira MC; Younes RN
J Surg Oncol; 2016 Apr; 113(5):570-4. PubMed ID: 26751412
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of pleural fluid data in patients with malignant effusion.
Bielsa S; Salud A; Martínez M; Esquerda A; Martín A; Rodríguez-Panadero F; Porcel JM
Eur J Intern Med; 2008 Jul; 19(5):334-9. PubMed ID: 18549935
[TBL] [Abstract][Full Text] [Related]
10. New approaches in the diagnostic procedure of malignant pleural effusions.
Terracciano D; Di Carlo A; Papa P; Cicalese M; Maietta P; Cecere C; Mariano A; Macchia V
Oncol Rep; 2004 Jul; 12(1):79-83. PubMed ID: 15201963
[TBL] [Abstract][Full Text] [Related]
11. Pleural fluid microbiota as a biomarker for malignancy and prognosis.
Kwok B; Wu BG; Kocak IF; Sulaiman I; Schluger R; Li Y; Anwer R; Goparaju C; Ryan DJ; Sagatelian M; Dreier MS; Murthy V; Rafeq S; Michaud GC; Sterman DH; Bessich JL; Pass HI; Segal LN; Tsay JJ
Sci Rep; 2023 Feb; 13(1):2229. PubMed ID: 36755121
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
[TBL] [Abstract][Full Text] [Related]
13. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
14. Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.
Alemán C; Manuel Porcel J; Ma Segura R; Alegre J; Esquerda A; Ruiz E; Bielsa S; de Sevilla TF
Med Clin (Barc); 2009 Oct; 133(12):449-53. PubMed ID: 19783262
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
[TBL] [Abstract][Full Text] [Related]
16. An Observational Study Evaluating the Performance of LENT Score in the Selected Population of Malignant Pleural Effusion from Lung Adenocarcinoma in Singapore.
Abisheganaden J; Verma A; Dagaonkar RS; Light RW
Respiration; 2018; 96(4):308-313. PubMed ID: 29945142
[TBL] [Abstract][Full Text] [Related]
17. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
[TBL] [Abstract][Full Text] [Related]
18. Predictive models for diagnosis of pleural effusions secondary to tuberculosis or cancer.
Sales RK; Vargas FS; Capelozzi VL; Seiscento M; Genofre EH; Teixeira LR; Antonangelo L
Respirology; 2009 Nov; 14(8):1128-33. PubMed ID: 19909461
[TBL] [Abstract][Full Text] [Related]
19. [Differential prognosis of patients with breast cancer with pleuritis carcinomatosa and with pulmonary lymphangiosis carcinomatosa].
Baur M; Schlappack O; Jakesz R; Dittrich C
Wien Klin Wochenschr; 1992; 104(23):714-6. PubMed ID: 1475980
[TBL] [Abstract][Full Text] [Related]
20. [Management of malignant pleural effusions].
Loddenkemper R
Pneumologie; 2005 Feb; 59(2):120-35. PubMed ID: 15724226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]